Nyxoah is a pioneering medical device company developing a breakthrough therapeutic solution for the treatment of Obstructive Sleep Apnea (OSA). Nyxoah’s team is driven by the vision that OSA sufferers should benefit from the latest and greatest innovations, for better health outcomes, higher patient comfort and quality of life. At the heart of Nyxoah’s innovation is a unique neurostimulation technology with more than 160 patents submitted worldwide. Nyxoah therapy will offer:
- Unparalleled clinical efficacy
- Increased patient comfort, therapy compliance and quality of life
- Minimally invasive approach, thus streamlining patient flow and reducing surgery related risks
- Positive health economics outcomes by reducing the burden of OSA and its comorbidities

Specialties : 




Employee Count Range: 


Company type: 

Privately Held

Founded year: 


Share this page